Molecular basis of exchangeable apolipoprotein function

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1483, Issue 1, 2000, Pages 15-36

  Narayanaswami, Vasanthy ^a   Ryan, Robert O ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Apolipophorin III; Apolipoprotein A I; Apolipoprotein E; Biophysical characterization; Conformational flexibility; Exchangeable apolipoprotein; Lipid free structure; Spectroscopy

Indexed keywords

APOLIPOPHORIN III; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; LIPOPROTEIN RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; ENZYME ACTIVATION; HUMAN; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; APOLIPOPROTEINS C; APOLIPOPROTEINS E; CRYSTALLOGRAPHY, X-RAY; ENZYME ACTIVATION; HUMANS; LIPOPROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PROTEIN CONFORMATION;

EID: 0033991858     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(99)00176-6     Document Type: Review

References (119)

1. Segrest J.P., Garber D.W., Brouillette C.G., Harvey S.C., Anantharamaiah G.M. Adv. Protein Res. 45:1994;303-369.
2. Segrest J.P., Jones M.K., DeLoof H., Brouillette C.G., Venkatachalapathi M., Anantharamaiah G.M. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res. 31:1992;141-166.
3. Breiter D.R., Kanost M.R., Benning M.M., Wesenberg G., Law J.H., Wells M.A., Rayment I., Holden H.M. Molecular structure of an apolipoprotein determined at 2.5-Å resolution. Biochemistry. 30:1991;603-608.
4. Wilson C., Wardell M.R., Weisgraber K.H., Mahley R.W., Agard D.A. Three dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science. 252:1991;1817-1822.
5. Borhani D.W., Rogers D.P., Engler J.A., Brouillette C.G. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc. Natl. Acad. Sci. USA. 94:1997;12291-12296.
6. Wang J., Gagne S., Sykes B.D., Ryan R.O. Insight into lipid surface recognition and reversible conformational adaptations of an exchangeable apolipoprotein by multidimensional NMR techniques. J. Biol. Chem. 272:1997;17912-17921.
7. Soulages J.L., Wells M.A. Lipophorin: the structure of an insect lipoprotein and its role in lipid transport in insects. Adv. Protein Chem. 45:1994;371-415.
8. Ryan R.O. Structural studies of lipoproteins and their apolipoprotein components. Biochem. Cell Biol. 72:1996;155-164.
9. Narayanaswami V., Ryan R.O. Protein-lipid interactions of apolipophorin III, a model exchangeable amphipathic apolipoprotein. Biochem. Soc. Trans. 25:1997;1113-1118.
10. Weisgraber K.H. Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45:1994;249-302.
11. Anantharamaiah G.M., Brouillette C.G. Structural models of human apolipoprotein A-I. Biochim. Biophys. Acta. 1256:1995;103-129.
12. R.O. Ryan, D.J. van der Horst, Insect lipids: biochemistry and role in energy production, Annu. Rev. Entomol. 45 (2000) in press.
13. Arresse E.L., Wells M.A. Adipokinetic hormone-induced lipolysis in fat body of an insect, Manduca sexta: synthesis of sn-1,2 diacylglycerols. J. Lipid Res. 38:1997;68-76.
14. 13C-NMR. Biochemistry. 34:1995;6755-6761.
15. Wells M.A., Ryan R.O., Kawooya J.K., Law J.H. Role of apolipophorin III in in vivo lipoprotein interconversions in adult Manduca sexta. J. Biol. Chem. 262:1987;4172-4176.
16. Soulages J.L., Wells M.A. Effect of diacylglycerol content on some physicochemical properties of the insect lipoprotein, lipophorin. Correlation with binding of apolipophorin III. Biochemistry. 33:1994;2356-2362.
17. Kawooya J.K., Meredith S.C., Wells M.A., Kézdy F.J., Law J.H. Physical and surface properties of insect apolipophorin III. J. Biol. Chem. 261:1986;13588-13591.
18. Ryan R.O., Oikawa K., Kay C.M. Conformational, thermodynamic and stability properties of insect apolipophorin III as determined by circular dichroism and fluorescence spectroscopy. J. Biol. Chem. 268:1993;1525-1530.
19. Weers P.M.M., Kay C.M., Oikawa K., Wientzek M., Van der Horst D.J., Ryan R.O. Factors affecting the stability and conformation of Locusta migratoria apolipophorin III. Biochemistry. 33:1994;3617-3624.
20. Weers P.M.M., Wang J., Van der Horst D.J., Kay C.M., Sykes B.D., Ryan R.O. Recombinant locust apolipophorin III: characterization and NMR spectroscopy. Biochim. Biophys. Acta. 1393:1998;99-107.
21. Wetterau J.R., Aggerbeck L.P., Rall S.C. Jr., Weisgraber K.H. Human apolipoprotein E3 in aqueous solution I. Evidence for two structural domains. J. Biol. Chem. 263:1988;6240-6248.
22. Narayanaswami V., Wang J., Schieve D., Kay C.M., Ryan R.O. A molecular trigger of lipid-binding induced opening of a helix bundle exchangeable apolipoprotein. Proc. Natl. Acad. Sci. USA. 96:1999;4366-4371.
23. Narayanaswami V., Kay C.M., Oikawa K., Ryan R.O. Structural and binding characteristics of the carboxyl terminal fragment of apolipophorin III from Manduca sexta. Biochemistry. 33:1994;13312-13320.
24. Narayanaswami V., Weers P.M.M., Bogerd J., Kooiman F.P., Kay C.M., Scraba D.G., Van der Horst D.J., Ryan R.O. Spectroscopic and lipid binding studies on the amino and carboxyl terminal fragments of Locusta migratoria apolipophorin III. Biochemistry. 34:1995;11822-11830.
25. Wang J., Narayanaswami V., Sykes B.D., Ryan R.O. Interhelical contacts are required for the helix bundle fold of apolipophorin III and its ability to interact with lipoproteins. Protein Sci. 7:1998;336-341.
26. Ryan R.O., Schieve D.S., Wientzek M., Narayanaswami V., Oikawa K., Kay C.M., Agellon L.B. Bacterial expression and site directed mutagenesis of a functional recombinant apolipoprotein. J. Lipid Res. 36:1995;1066-1072.
27. V. Narayanaswami, Y. Yamauchi, P.M.M. Weers, H. Maekawa, R. Sato, K. Tsuchida, K. Oikawa, C.M. Kay, R.O. Ryan, Spectroscopic characterization of the conformational adaptability of Bombyx mori apolipophorin III, Eur. J. Biochem. (1999) revised manuscript submitted.
28. Hård K., Van Doorn J.M., Thomas-Oates J.E., Kamerling J.P., Van der Horst D.J. Structure of the Asn-linked oligosaccharides of apolipophorin III from the insect Locusta migratoria. Carbohydrate-linked 2-amino-ethylphosphonate as a constituent of a glycoprotein. Biochemistry. 32:1993;766-775.
29. Weers P.M.M., Narayanaswami V., Kay C.M., Ryan R.O. Interaction of an exchangeable apolipoprotein with phospholipid vesicles and lipoprotein particles. Role of leucines 32, 34 and 95 in Locusta migratoria apolipophorin III. J. Biol. Chem. 274:1999;21804-21810.
30. Soulages J.L., Pennington J., Bendavid O., Wells M.A. Role of glycosylation in the lipid binding activity of the exchangeable apolipoprotein, apolipophorin III. Biochem. Biophys. Res. Commun. 243:1998;372-376.
31. Wientzek M., Kay C.M., Oikawa K., Ryan R.O. Binding of insect apolipophorin III to dimyristoylphosphatidylcholine vesicles: evidence for a conformational change. J. Biol. Chem. 269:1994;4605-4612.
32. Liu H., Scraba D.G., Ryan R.O. Prevention of phospholipase-C induced aggregation of low density lipoprotein by amphipathic apolipoproteins. FEBS Lett. 316:1993;27-33.
33. Suits A.G., Chait A., Aviram M., Heinecke J.W. Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam cell formation. Proc. Natl. Acad. Sci. USA. 86:1989;2713-2717.
34. Singh T.K.A., Scraba D.G., Ryan R.O. Conversion of human low density lipoprotein into a very low density lipoprotein-like particle in vitro. J. Biol. Chem. 267:1992;9275-9280.
35. Parks J.S., Martin J.A., Johnson F.L., Rudel L.L. Fusion of low density lipoproteins with cholesterol ester-phospholipid microemulsions. J. Biol. Chem. 260:1985;3155-3163.
36. Cole K.D., Fernando-Warnakulasuriya G.J.P., Boguski M.S., Freeman M., Gordon J.I., Clark W.A., Law J.H., Wells M.A. Primary structure and comparative sequence analysis of an insect apolipoprotein: apolipophorin III from Manduca sexta. J. Biol. Chem. 262:1987;11794-11800.
37. Narayanaswami V., Frolov A., Schroeder F., Oikawa K., Kay C.M., Ryan R.O. Fluorescence studies of lipid-association induced conformational adaptations of an exchangeable amphipathic apolipoprotein. Arch. Biochem. Biophys. 334:1996;143-150.
38. Narayanaswami V., Wang J., Kay C.M., Scraba D.G., Ryan R.O. Disulfide bond engineering to monitor conformational opening of apolipophorin III during lipid binding. J. Biol. Chem. 271:1996;26855-26862.
39. Wang J., Sahoo D., Sykes B.D., Ryan R.O. NMR evidence for a conformational adaptation of apolipophorin III upon lipid association. Biochem. Cell Biol. 76:1998;276-283.
40. Raussens V., Goormaghtigh E., Narayanaswami V., Ryan R.O., Ruysschaert J.-M. J Alignment of apolipophorin III α-helices in complex with dimyristoylphosphatidylcholine: a unique spatial orientation. J. Biol. Chem. 270:1995;12542-12547.
41. Raussens V., Narayanaswami V., Goormaghtigh E., Ryan R.O., Ruysschaert J.-M. Hydrogen/deuterium exchange kinetics of apolipophorin III in lipid free and phospholipid bound states. An analysis by Fourier transform infrared spectroscopy. J. Biol. Chem. 271:1996;23089-23095.
42. Sahoo D., Narayanaswami V., Oikawa K., Kay C.M., Ryan R.O. Fluorescence studies of exchangeable apolipoprotein-lipid interactions. Superficial association of apolipophorin III with lipoprotein surfaces. J. Biol. Chem. 273:1998;1403-1408.
43. Soulages J.L., Salamon Z., Wells M.A., Tollin G. Low concentrations of diacylglycerol promote the binding of apolipophorin III to a phospholipid bilayer: a surface plasmon resonance spectroscopy study. Proc. Natl. Acad. Sci. USA. 92:1995;5650-5654.
44. Smith A.F., Owen L.M., Strobel L.M., Chen H., Kanost M.R., Hanneman E., Wells M.A. Exchangeable apolipoproteins of insects have a common structural motif. J. Lipid Res. 35:1994;1976-1984.
45. Dugi K.A., Dichek H.L., Santamarina-Fojo S. Human hepatic and lipoprotein lipase: the loop covering the catalytic site mediates lipase substrate specificity. J. Biol. Chem. 270:1995;25396-25401.
46. Soulages J.L., Bendavid O.J. The lipid binding activity of the exchangeable apolipoprotein apolipophorin III correlates with the formation of a partially folded conformation. Biochemistry. 37:1998;10203-10210.
47. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
48. Kowal R.C., Herz J., Goldstein J.L., Esser V., Brown M.S. Low density lipoprotein receptor-related protein mediates uptake of cholesterol esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. USA. 86:1989;5810-5814.
49. Takahashi S., Kawarabayasi Y., Nakai Y., Saskai J., Yamamoto T. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. USA. 89:1992;9252-9256.
50. Aggerbeck L.P., Wetterau J.R., Weisgraber K.H., Wu C.-S.C., Lindgren F.T. Human apolipoprotein E3 in aqueous solution II. Properties of the amino- and carboxyl-terminal domains. J. Biol. Chem. 263:1988;6249-6258.
51. Weisgraber K.H. Apolipoprotein E distribution among human plasma lipoproteins: role of cysteine-arginine interchange at position 112. J. Lipid Res. 31:1990;1503-1511.
52. Westerlund J.A., Weisgraber K.H. Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. J. Biol. Chem. 268:1993;15745-15750.
53. Mahley R.W., Innerarity T.L., Pitas R.E., Weisgraber K.H., Brown J.H., Gross E. Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. J. Biol. Chem. 252:1977;7279-7287.
54. Weisgraber K.H., Innerarity T.L., Mahley R.W. Role of the lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J. Biol. Chem. 253:1978;9053-9062.
55. Innerarity T.L., Friedlander B.J., Rall S.C. Jr., Weisgraber K.H., Mahley R.W. The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. J. Biol. Chem. 258:1983;12341-12347.
56. Innerarity T.L., Pitas R.E., Mahley R.W. Binding of arginine-rich (E) apolipoprotein after recombination with phospholipid vesicles to low density lipoprotein receptors of fibroblasts. J. Biol. Chem. 254:1979;4186-4190.
57. Innerarity T.L., Weisgraber K.H., Arnold K.S., Rall S.C. Jr., Mahley R.W. Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation. J. Biol. Chem. 259:1984;7261-7267.
58. Dong L.-M., Parkin S., Trakhanov S., Rupp B., Simmons T., Arnold K.S., Newhouse Y.M., Innerarity T.L., Weisgraber K.H. Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia. Nat. Struct. Biol. 3:1996;718-722.
59. 4 in humans. J. Clin. Invest. 78:1986;815-821.
60. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
61. Dong L.-M., Wilson C., Wardell M.R., Simmons T., Mahley R.W., Weisgraber K.H., Agard D.A., Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem. 269:1994;22358-22365.
62. Wilson C., Mau T., Weisgraber K.H., Wardell M.R., Mahley R.W., Agard D.A. Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein. Structure. 2:1994;713-718.
63. Dong L.-M., Weisgraber K.H. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J. Biol. Chem. 271:1996;19053-19057.
64. K.H. Weisgraber, S. Lund-Katz, M.C. Phillips, in: N.E. Miller, A.R. Tall (Eds.), High Density Lipoproteins and Atherosclerosis III, Elsevier, Amsterdam, 1992, pp. 175-181.
65. Fisher C.A., Ryan R.O. Lipid binding-induced conformational changes in the N-terminal domain of apolipoprotein E. J. Lipid Res. 40:1999;93-99.
66. de Pauw M., Vanloo B., Weisgraber K.H., Rosseneu M. Comparison of lipid binding and lecithin:cholesterol acyltransferase activation of the amino- and carboxyl-terminal domains of human apolipoprotein E3. Biochemistry. 34:1995;10953-10960.
67. Raussens V., Fisher C.A., Goormaghtigh E., Ryan R.O., Ruysschaert J.-M. The LDL receptor active conformation of apolipoprotein E. Helix organization in N-terminal domain-phospholipid disc particles. J. Biol. Chem. 273:1998;25825-25830.
68. f 100-400 hypertryglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. J. Biol. Chem. 258:1983;4526-4533.
69. Krul E.S., Tikkanen M., Schonfeld G. Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: importance for apolipoprotein E function. J. Lipid Res. 29:1988;1309-1325.
70. Windler E., Chao Y., Havel R.J. Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat. J. Biol Chem. 255:1980;5475-5480.
71. Windler E., Chao Y., Havel R.J. Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apolipoproteins. J. Biol. Chem. 255:1980;8303-8307.
72. Windler E., Havel R.J. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by perfused rat liver. J. Lipid Res. 26:1985;556-565.
73. Shelburne F., Hanks J., Meyers W., Quarfordt S. Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat. J. Clin. Invest. 65:1980;652-658.
74. Kowal R.C., Herz J., Weisgraber K.H., Mahley R.W., Brown M.S., Goldstein J.L. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265:1990;10771-10779.
75. Weisgraber K.H., Mahley R.W., Kowal R.C., Herz J., Goldstein J.L., Brown M.S. Apolipoprotein C-I modulates the interaction of apolipoprotein E with β-migrating very low density lipoproteins (β-VLDL) and inhibits binding of β-VLDL to low density lipoprotein receptor-related protein. J. Biol. Chem. 265:1990;22453-22459.
76. Borensztajn J., Kotlar T.J. Hepatic uptake of phospholipid-depleted chylomicrons in vivo. Comparison of uptake with chylomicron remnants. Biochem. J. 200:1981;547-553.
77. Borensztajn J., Getz G.S., Kotlar T.J. Uptake of chylomicron remnants by the liver: further evidence for the modulating role of phospholipids. J. Lipid Res. 29:1988;1087-1096.
78. Sehayek E., Lewin-Velvert U., Chajek-Shaul T., Eisenberg S. Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein. J. Clin. Invest. 88:1991;553-560.
79. Fass D., Blacklow S., Kim P., Berger J.M. Molecular basis of familial hypercholesterolemia from structure of LDL receptor module. Nature. 388:1997;691-693.
80. Russell D.W., Brown M.S., Goldstein J.L. Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins. J. Biol. Chem. 264:1989;21682-21688.
81. Dirlam K.A., Gretch D.G., LaCount D.J., Sturley S.L., Attie A.D. Expression and characterization of a truncated, soluble, low-density lipoprotein receptor. Protein Expr. Purif. 8:1996;489-500.
82. Simmons T., Newhouse Y.M., Arnold K.S., Innerarity T.L., Weisgraber K.H. Human low density lipoprotein receptor fragment. Successful refolding of a functionally active ligand-binding domain produced in Escherichia coli. J. Biol. Chem. 272:1997;25531-25536.
83. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36:1995;211-228.
84. Yokoyama S. Apolipoprotein mediated cellular cholesterol efflux. Biochim. Biophys. Acta. 1392:1998;1-15.
85. Phillips M.C., Gillotte K.L., Haynes M.P., Johnson W.J., Lund-Katz S., Rothblat G.H. Mechanisms of high density lipoprotein mediated efflux of cholesterol from plasma membranes. Atherosclerosis. 137:1998;S13-17.
86. Tall A.R. An overview of reverse cholesterol transport. Eur. Heart J. 19:1998;A31-35.
87. von Eckardstein A., Assmann G. High density lipoproteins and reverse cholesterol transport: lessons from mutations. Atherosclerosis. 137:1998;S7-11.
88. Nolte R.T., Atkinson D. Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism. Biophys. J. 63:1992;1221-1239.
89. Davidson W.S., Hazlett T., Mantulin W.W., Jonas A. The role of apolipoprotein A-I domains in lipid binding. Proc. Natl. Acad. Sci. USA. 93:1996;13605-13610.
90. Laccotrippe M., Makrides S.C., Jonas A., Zannis V.I. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein. J. Biol. Chem. 272:1997;17511-17522.
91. Roberts L.M., Ray M.J., Shih T.-W., Hayden E., Reader M.M., Brouillette C.G. Structural analysis of apolipoprotein A-I: limited proteolysis of methionine-reduced and-oxidized lipid-free and lipid-bound human apoA-I. Biochemistry. 36:1997;7615-7624.
92. Kiss R.S., Kay C.M., Ryan R.O. Amphipathic α-helix bundle organization of lipid-free chicken apolipoprotein A-I. Biochemistry. 38:1999;4327-4334.
93. Kiss R.S., Ryan R.O., Hicks L.D., Oikawa K., Kay C.M. Physical properties of apolipoprotein A-I from the chicken, Gallus domesticus. Biochemistry. 32:1993;7872-7878.
94. Sparks D.L., Frank P.G., Braschi S., Neville T.A.-M., Marcel Y.L. Effect of apolipoprotein A-I lipidation on the formation and function of pre-β and α-migrating LpA-I particles. Biochemistry. 38:1999;1727-1735.
95. Rogers D.P., Brouillette C.G., Engler J.A., Tendian S.W., Roberts L., Mishra V.K., Anantharamaiah G.M., Lund-Katz S., Phillips M.C., Ray M.J. Truncation of the amino terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation. Biochemistry. 36:1997;288-300.
96. Karathanasis S.K., Zannis V.I., Breslow J.L. Isolation and characterization of the human apolipoprotein A-I gene. Proc. Natl. Acad. Sci. USA. 80:1983;6147-6151.
97. Rogers D.P., Roberts L.M., Lebowitz J., Datta G., Anantharamaiah G.M., Engler J.A., Brouillette C.G. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions. Biochemistry. 37:1998;11714-11725.
98. Rogers D.P., Roberts L.M., Lebowitz J., Engler J.A., Brouillette C.G. Structural analysis of apolipoprotein A-I: effects of amino- and carboxy-terminal deletions on the lipid-free structure. Biochemistry. 37:1998;945-955.
99. Ji Y., Jonas A. Properties of an N-terminal proteolytic fragment of apolipoprotein A-I in solution and in reconstituted high density lipoproteins. J. Biol. Chem. 270:1995;11290-11297.
100. McGuire K.A., Davidson W.S., Jonas A. High yield overexpression and characterization of human recombinant proapolipoprotein A-I. J. Lipid Res. 37:1996;1519-1528.
101. Reijngoud D.J., Phillips M.C. Mechanism of dissociation of human apolipoprotein A-I from complexes with dimyristoylphosphatidylcholine as studied by guanidine hydrochloride denaturation. Biochemistry. 21:1982;2969-2976.
102. Holvoet P., Zhao Z., Vanloo B., Vos R., Deridder E., Dhoest A., Taveirne J., Brouwers E., Demarsin E., Engelborghs Y., Rosseneu M., Collen D., Brasseur R. Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants. Biochemistry. 34:1995;13334-13342.
103. Frank P.G., Bergeron J., Emmanuel F., Lavigne J.P., Sparks D.L., Denefle P., Rassart E., Marcel Y.L. Deletion of central alpha-helices in human apolipoprotein A-I: effect on phospholipid association. Biochemistry. 36:1997;1798-1806.
104. Bergeron J., Frank P.G., Emmanuel F., Latta M., Zhao Y., Sparks D.L., Rassart E., Denèfle P., Marcel Y.L. Characterization of human apolipoprotein A-I expressed in Escherichia coli. Biochim. Biophys. Acta. 1344:1997;139-152.
105. Frank P.G., N'Guyen D., Franklin V., Neville T., Desforges M., Rassart E., Sparks D.L., Marcel Y.L. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins. Biochemistry. 37:1998;13902-13909.
106. Sorci-Thomas M.G., Kearns M.W., Lee J.P. Apolipoprotein A-I domains involved in lecithin:cholesterol acyltransferase activation: structure-function relationships. J. Biol. Chem. 268:1993;21403-21409.
107. Sorci-Thomas M.G., Curtiss L., Parks J.S., Thomas M.J., Kearns M.W. Alteration in apolipoprotein A-I 22-mer repeat order results in a decrease in lecithin:cholesterol acyltransferase reactivity. J. Biol. Chem. 272:1997;7278-7284.
108. Sorci-Thomas M.G., Parks J.S., Kearns M.W., Pate G.N., Zhang C., Thomas M.J. High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression. J. Lipid Res. 37:1996;673-683.
109. Sorci-Thomas M.G., Curtiss L., Parks J.S., Thomas M.J., Kearns M.W., Landrum M. The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation. J. Biol. Chem. 273:1998;11776-11782.
110. Holvoet P., Zhao Z., Deridder E., Dhoest A., Collen D. Effects of deletion of the carboxyl-terminal domain of apoA-I or of its substitution with helices of apoA-II on in vivo and in vitro lipoprotein association. J. Biol. Chem. 271:1996;19395-19401.
111. Holvoet P., Danloy S., Collen D. Role of the carboxy-terminal domain of human apolipoprotein A-I in high-density-lipoprotein metabolism. A study based on deletion and substitution variants in transgenic mice. Eur. J. Biochem. 245:1997;642-647.
112. 166 paired helix of apolipoprotein A-I in lecithin:cholesterol acyltransferase activation. J. Biol. Chem. 272:1997;15967-15972.
113. Jonas A. Reconstitution of high-density lipoproteins. Methods Enzymol. 128:1986;553-582.
114. Phillips J.C., Wriggers W., Li Z., Jonas A., Schulten K. Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks. Biophys. J. 73:1997;2337-2346.
115. Koppakka V., Silvestro L., Engler J.A., Brouillette C.G., Axelsen P.H. The structure of human lipoprotein A-I. Evidence for the 'belt' model. J. Biol. Chem. 274:1999;14541-14544.
116. Weisgraber K.H., Mahley R.W. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 10:1996;1485-1494.
117. Pitas R.E., Ji Z.S., Weisgraber K.H., Mahley R.W. The role of apolipoprotein E in modulating neurite outgrowth: potential effect of intracellular apolipoprotein E. Biochem. Soc. Trans. 26:1998;257-262.
118. Lemieux M.J., Mezei C., Breckenridge W.C. Secretion and processing of apolipoprotein A-I in the avian sciatic nerve during development. J. Neurosci. Res. 44:1996;594-605.
119. Sun D., Zeigler R., Milligan C.E., Farbach S., Schwartz L.M. Apolipophorin III is dramatically upregulated during the programmed cell death of insect skeletal muscle and neurons. J. Neurobiol. 26:1995;119-129.